Dr. Narla on Advances Made With Precision Medicine in Oncology

Video

Goutham Narla, MD, PhD, discusses advances made with precision medicine in oncology.

Goutham Narla, MD, PhD, an associate professor in the Department of Medicine; chief of the Division of Genetic Medicine of the Department of Medicine; and associate director of the Medical Scientist Training Program at the University of Michigan, discusses advances made with precision medicine in oncology.

Many advances have been made in cancer genetics in recent years, including the identification of additional disease-causing variants, says Narla. Previous knowledge had been limited to the presence of BRCA1/2 mutations and some of the mismatch repair genes, but now other genes such as PALB2 and other genes in that family have been discovered, adds Narla. This information has resulted in the expansion of testing opportunities for patients with cancer.

Another exciting development is that some gene variants have been found to be predictive of response to therapy for patients whose tumors harbor certain mutations. This knowledge has changed the treatment of patients with cancer who have these variants, Narla concludes.

Related Videos
Arya Amini, MD
Adrianna Masters, MD, PhD,
Chul Kim, MD, MPH
Andrew Ip, MD
In this final episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss a roadmap of artificial intelligence (AI) advances in the next 5 to 10 years.
In this eighth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools are being developed to match the right patient to the right drug on the right clinical trial.
In this seventh episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss how artificial intelligence tools may be utilized to improve wait time for treatment, to provide more time for provider-patient interactions, and more.
In this final episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, shed light on clinical outcomes following surgery of the primary tumor in patients with stage IV breast cancer.
In this sixth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss potential opportunities to leverage artificial intelligence tools in cancer screening, diagnosis, staging, and prognosis.
Christopher M. Gallagher, MD